Peripheral T-cell and NK cell lymphoproliferative disorders: cell of origin, clinical and pathological implications.

TitlePeripheral T-cell and NK cell lymphoproliferative disorders: cell of origin, clinical and pathological implications.
Publication TypeJournal Article
Year of Publication2015
AuthorsInghirami G, Chan WC, Pileri S
Corporate AuthorsAIRC 5xMille Consortium ‘Genetics-Driven Targeted Management of Lymphoid Malignancies’
JournalImmunol Rev
Date Published2015 Jan
KeywordsAnimals, Carcinogenesis, Chromatin Assembly and Disassembly, Humans, Killer Cells, Natural, Lymphoma, Extranodal NK-T-Cell, Lymphoma, T-Cell, Peripheral, Neoplastic Stem Cells, T-Lymphocytes, Transcription Factors

T-cell lymphoproliferative disorders are a heterogeneous group of neoplasms with distinct clinical-biological properties. The normal cellular counterpart of these processes has been postulated based on functional and immunophenotypic analyses. However, T lymphocytes have been proven to be remarkably capable of modulating their properties, adapting their function in relationship with multiple stimuli and to the microenvironment. This impressive plasticity is determined by the equilibrium among a pool of transcription factors and by DNA chromatin regulators. It is now proven that the acquisition of specific genomic defects leads to the enforcement/activation of distinct pathways, which ultimately alter the preferential activation of defined regulators, forcing the neoplastic cells to acquire features and phenotypes distant from their original fate. Thus, dissecting the landscape of the genetic defects and their functional consequences in T-cell neoplasms is critical not only to pinpoint the origin of these tumors but also to define innovative mechanisms to re-adjust an unbalanced state to which the tumor cells have become addicted and make them vulnerable to therapies and targetable by the immune system. In our review, we briefly describe the pathological and clinical aspects of the T-cell lymphoma subtypes as well as NK-cell lymphomas and then focus on the current understanding of their pathogenesis and the implications on diagnosis and treatment.

Alternate JournalImmunol Rev
PubMed ID25510275
Related Faculty: 
Giorgio Inghirami, M.D.

Pathology & Laboratory Medicine 1300 York Avenue New York, NY 10065 Phone: (212) 746-6464
Surgical Pathology: (212) 746-2700